Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,001 USD | -99,76 % | -99,76 % | -99,91 % |
Resumen de negocios
Número de empleados: 174
Ventas por actividad
USD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Abnormal Uterine Bleeding Therapeutic Devices
100,0
%
| 52 | 100,0 % | 50 | 100,0 % | -3,47 % |
Ventas por región
USD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 52 | 100,0 % | 50 | 100,0 % | -3,47 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Todd Usen
CEO | Chief Executive Officer | - | 02/01/23 |
Joel R. Jung
DFI | Director of Finance/CFO | 66 | 01/07/20 |
Chief Tech/Sci/R&D Officer | 58 | 01/01/11 | |
Chief Operating Officer | 62 | 01/01/10 | |
Caroline Corne
IRC | Investor Relations Contact | - | - |
Joanne Long
AUD | Comptroller/Controller/Auditor | - | 01/02/21 |
Wendy Bowman
HRO | Human Resources Officer | - | 01/01/15 |
Kaile Zagger
PRN | Corporate Officer/Principal | - | 21/03/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Uri Geiger
CHM | Chairman | 56 | 09/02/23 |
Derrick Sung
BRD | Director/Board Member | 51 | 20/07/22 |
Niquette L. Hunt
BRD | Director/Board Member | 59 | 01/06/21 |
Todd Usen
CEO | Chief Executive Officer | - | 02/01/23 |
Catherine Coste
BRD | Director/Board Member | 58 | 01/02/21 |
Daniel Cohen
BRD | Director/Board Member | - | 01/03/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 8 878 582 | 2 731 338 ( 30,76 %) | 0 | 30,76 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
-99,91 % | 8,88 mil | |
+12,37 % | 129 mil M | |
-9,23 % | 10,77 mil M | |
+2,17 % | 9049,34 M | |
+18,79 % | 7380,73 M | |
+20,77 % | 4875,59 M | |
+6,97 % | 3413,66 M | |
-1,41 % | 3065,58 M | |
-5,07 % | 2236,45 M | |
-4,22 % | 2118,95 M |
- Bolsa de valores
- Acciones
- Acción UTRS
- Empresa Minerva Surgical, Inc.